Project Grant R01DA062680
Award Date
5/1/25
Completion Date
3/31/30
Dollars Obligated
$714K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
This $1,537,749 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the molecular mechanisms by which HIV and methamphetamine exposure activate the astrocyte-specific NLRP6 inflammasome, leading to neuroinflammation and associated neurological disorders in people living with HIV ("NeuroHIV"). The research utilizes in vitro, ex vivo, and in vivo approaches to elucidate the role of the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,411,610 in funding to the University of Nebraska Medical Center (UNMC) to investigate the combined effects of HIV Tat protein and opioids on glial-neuronal interactions, with a focus on the role of extracellular microRNAs. The research aims to elucidate how HIV and opioid co-morbidity exacerbates synaptic injury and dysfunction, and to...
This federal Project Grant award, totaling $983,672.00 and spanning from September 30, 2024 to July 31, 2027, is funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award will support research at the University of California, San Francisco (UCSF) to characterize the in-situ interactions between HIV, methamphetamine use, and the central nervous system (CNS) in people living with HIV. The researchers will leverage a unique...
The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $2,035,194 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Rosalind Franklin University of Medicine & Science in North Chicago, Illinois. The grant supports research to characterize the mechanisms by which a positive allosteric modulator of the α7 nicotinic acetylcholine receptor, PNU-120596, can provide neuroprotection against HIV Tat protein...
This federal Project Grant award, valued at $5,147,311.00 and issued by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to study the immune mechanisms that shape the blood-brain barrier (BBB) in people living with HIV and cocaine use disorder. The key objectives are to: 1) Determine the contribution of immune cell phenotypes to BBB permeability in people living with HIV with and without cocaine use disorder; 2) Assess the...
This $3,469,296 Project Grant was awarded by the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research to determine the effects of methamphetamine on inflammasome activation and T cell dysfunction during HIV infection, and to examine the therapeutic potential of targeting autophagy to reduce inflammasome activation and restore T cell function. Specific aims include investigating the impact of...
This is a Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279). The $3,472,327 grant, awarded on May 15, 2024, will support a 5-year research project entitled "The Impact of Poly-Substance Use on the Crosstalk between Microglia, Astrocytes, and Neurons that Regulates HIV Latency." The project, led by Case Western Reserve University, aims to investigate how the combined use of methamphetamine and opioids...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund research at Drexel University to study the effects of HIV infection and estrogen on the regulation of cocaine-related behaviors. The $227,250 award, active from August 1, 2024 to July 31, 2026, will support three research aims: 1) determining the effects of HIV infection and cocaine exposure on estradiol levels and receptor expression in the...
This federal Project Grant award for $185,148, provided by the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the HIV, Equity, and Addiction Training (HEAT) Program. The award will fund a career mentoring program led by Dr. Ellen Eaton at the University of Alabama at Birmingham (UAB) to develop diverse clinician-scientists who conduct patient-oriented research at the intersection of substance use disorders and HIV. Key activities...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $882,308 to the University of Nebraska Medical Center (UNMC) to investigate the molecular mechanisms underlying the interplay between HIV, cocaine, and antiretroviral therapy (ART) in activating the NLRP3 inflammasome signaling pathway, leading to microglial pyroptosis and neuroinflammation. The research aims to elucidate how these...